Skip to content

Clinical trials

Expanded access trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Expanded access Country / region: Austria Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20062

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
No longer available11
Approved for marketing7
Available1
Temporarily not available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Pfizer3
Bayer2
Eli Lilly and Company2
Amgen1
AstraZeneca1
Bristol-Myers Squibb1
Gilead Sciences1
Janssen-Cilag International NV1
MaaT Pharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell2
Recurrence2
Breast Neoplasms1
COVID-191
Carcinoma, Hepatocellular1
Carcinoma, Non-Small-Cell Lung1
Colorectal Neoplasms1
Coronary Artery Disease1
Dermatitis, Atopic1
Eczema1

Trials

Showing 26 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.